| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 283173-80-8 | 2-Bromo-8-fluoro-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one | C11H8BrFN2O |
| 283173-84-2 | 4-(8-Fluoro-3,4,5,6-tetrahydro-6-oxo-1H-azepino[5,4,3-cd]indol-2-yl)benzaldehyde | C18H13FN2O2 |
| 283174-18-5 | 11beta-Hydroxycedrelone | C26H30O6 |
| 283584-52-1 | 5-Fluoro-3-hydrazonoindolin-2-one | C8H6FN3O |
| 283609-79-0 | L-Leucyl-L-seryl-L-lysyl-L-leucinamide | C21H42N6O5 |
| 284019-34-7 | Denibulin | C18H19N5O3S |
| 284027-36-7 | 8-Trifluoromethyl-1,2,3,4-tetrahydroisoquinoline | C10H10F3N |
| 284028-89-3 | XAV 939 | C14H11F3N2OS |
| 284028-90-6 | DR 2313 | C8H10N2OS |
| 284030-57-5 | 4-Amino-2,3-difluoro-5-nitrobenzoic acid | C7H4F2N2O4 |
| 284030-58-6 | Methyl 4-amino-2,3-difluoro-5-nitrobenzoate | C8H6F2N2O4 |
| 284035-33-2 | NPS 2143 | C24H25ClN2O2 |
| 284039-66-3 | Cyclopropylmethyl beta-D-glucopyranoside | C10H18O6 |
| 284049-75-8 | 3-Butyl-1-methylimidazolium acetate | C8H15N2.C2H3O2 |
| 284461-73-0 | Sorafenib | C21H16ClF3N4O3 |
| 284461-74-1 | N-Desmethyl Sorafenib | C20H14ClF3N4O3 |
| 284462-37-9 | 4-(4-Aminophenoxy)-N-methylpicolinamide | C13H13N3O2 |
| 284463-96-3 | 3,4,5-Trifluorotoluene | C7H5F3 |
| 284472-79-3 | 1-(11bS)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl-piperidine | C25H22NO2P |
| 284477-00-5 | 2-Quinolineacetic acid | C11H9NO2 |
| 284493-53-4 | 3-N-Boc-amino-3-(3-methoxyphenyl)propionic acid | C15H21NO5 |
| 284493-56-7 | 3-N-Boc-amino-3-(2-fluorophenyl)propionic acid | C14H18FNO4 |
| 284493-58-9 | Boc-3-amino-3-(3'-bromophenyl)propionic acid | C14H18BrNO4 |
| 284493-59-0 | 3-N-Boc-amino-3-(3-fluorophenyl)propionic acid | C14H18FNO4 |
| 284493-65-8 | Boc-3-amino-3-(4'-chlorophenyl)propionic acid | C14H18ClNO4 |
| 284493-66-9 | Boc-3-amino-3-(2'-chlorophenyl)propionic acid | C14H18ClNO4 |
| 284493-67-0 | 3-Boc-amino-3-(3'-chlorophenyl)propioinic acid | C14H18ClNO4 |
| 284493-72-7 | 3-(Boc-amino)-3-(4-fluorophenyl)propionic acid | C14H18FNO4 |
| 284663-02-1 | 4-Pentenyl O-6-deoxy-alpha-L-galactopyranosyl-(1$rarr$2)-O-beta-D-galactopyranosyl-(1$rarr$3)-O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1$rarr$3)-O-alpha-D-galactopyranosyl-(1$rarr$4)-O-beta-D-galactopyranosyl-(1$rarr$4)-beta-D-glucopyranoside | C43H73NO30 |
| 284670-98-0 | N,N'-Bis[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea | C27H24N6O5 |
| 284679-97-6 | 3-Nitro-4-(1-pyrrolidino)benzaldehyde | C11H12N2O3 |
| 285135-89-9 | (3E)-4-Ethoxy-1,1-difluoro-3-buten-2-one | C6H8F2O2 |
| 285158-15-8 | N-[4-Bromo-2-(2-chlorobenzoyl)phenyl]-2-chloroacetamide | C15H10BrCl2NO2 |
| 285549-57-7 | 5-(Hydroxymethyl)uridine 2',3',5'-triacetate | C16H20N2O10 |
| 285554-31-6 | Amyloid peptide 1-46 | C223H347N59O65S |
| 285570-60-7 | Caspase-3 Inhibitor III | C21H31ClN4O11 |
| 285978-18-9 | Uridine-13C9-15N2 5'-(tetrahydrogen triphosphate) sodium salt | C9H15N2O15P3.x(Na) |
| 285978-24-7 | N-(Phosphonomethyl)glycine-2-13C-15N | C3H8NO5P |
| 285983-48-4 | Doramapimod | C31H37N5O3 |
| 285984-25-0 | 5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-ylamine | C14H19N3 |
| 285986-88-1 | N-[2-[(4-Chlorophenyl)amino]-1-methyl-2-oxoethoxy]-3,5-bis(trifluoromethyl)benzamide | C18H13ClF6N2O3 |
| 285991-64-2 | 4-Chlorofuro[3,4-c]pyridin-3(1H)-one | C7H4ClNO2 |
| 285995-73-5 | 2-(4-Pyridinyl)-4-thiazolol | C8H6N2OS |
| 285998-87-0 | 4-Undecenoic acid ethyl ester | C13H24O2 |
| 286007-27-0 | 5-(3-Thienyl)-3-bromopyridine | C9H6BrNS |
| 286011-68-5 | 2-Pyridineethanamine-1-oxide | C7H10N2O |
| 286014-25-3 | 1,3-Bis(2,6-diisopropylphenyl)imidazolium tetrafluoroborate | C27H37N2.BF4 |
| 286014-34-4 | 1,3-Diisopropylimidazolium tetrafluoroborate | C9H17N2.BF4 |
| 286014-38-8 | N,N'-Dicyclohexylimidazolium tetrafluoroborate | C15H25N2.BF4 |
| 286014-42-4 | 1,3-Bis(1-adamantyl)imidazolium tetrafluoroborate | C23H33N2.BF4 |